Luitpold Pharmaceuticals

Luitpold Pharmaceuticals was a specialty pharmaceutical company based in Shirley, New York, that focused on the development and marketing of injectable drugs. The company was widely recognized for its leadership in the iron deficiency therapeutic area, commercializing major products such as Venofer and Injectafer for patients with chronic kidney disease and anemia. In addition to its human health portfolio, Luitpold operated a successful animal health division, notably producing Adequan for the treatment of osteoarthritis in horses and dogs. In 2019, the company was fully integrated into its sister company, American Regent, a member of the Daiichi Sankyo Group, to streamline operations and unify its corporate identity. The legacy of Luitpold's products continues to be managed by American Regent today.